Page last updated: 2024-09-04

glucagon and rosiglitazone

glucagon has been researched along with rosiglitazone in 5 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(rosiglitazone)
Trials
(rosiglitazone)
Recent Studies (post-2010) (rosiglitazone)
26,0391,4983,0544,7495561,818

Protein Interaction Comparison

ProteinTaxonomyglucagon (IC50)rosiglitazone (IC50)
CDGSH iron-sulfur domain-containing protein 1Rattus norvegicus (Norway rat)1.1
Bile salt export pumpHomo sapiens (human)4.5853
Carbonic anhydrase 2Homo sapiens (human)4.069
Peroxisome proliferator-activated receptor alphaMus musculus (house mouse)0.08
Thromboxane-A synthase Homo sapiens (human)3.56
Amine oxidase [flavin-containing] BHomo sapiens (human)0.832
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)0.2481
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.038
ATP-binding cassette sub-family C member 8Homo sapiens (human)0.048
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)0.048
Sodium/bile acid cotransporterHomo sapiens (human)5.1
CDGSH iron-sulfur domain-containing protein 2Homo sapiens (human)2.29
CDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)0.731

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buckingham, RE; Lister, CA; Smith, SA; Toseland, CD1
Dharmalingam, M; Kumar, P1
Roden, M; Stingl, H1
Choi, MS; Jeon, SM; Jeong, YJ; Kim, DJ; Kim, HJ; Kwon, JH; Lee, MK; Moon, KD; Park, YB1
Chodavarapu, H; Elased, KM; Grobe, N; Madhu, M; Salem, ES; Somineni, HK1

Reviews

2 review(s) available for glucagon and rosiglitazone

ArticleYear
New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
    The Journal of the Association of Physicians of India, 2001, Jan-25, Volume: 49 Spec No

    Topics: Amyloid; Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Peptide Fragments; Protein Precursors; Rosiglitazone; Thiazoles; Thiazolidinediones

2001
[Future targets in the treatment of type 2 diabetes].
    Wiener klinische Wochenschrift, 2004, Apr-30, Volume: 116, Issue:7-8

    Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycated Hemoglobin; Glycogen Synthase Kinase 3; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Lipid Peroxidation; Metabolic Syndrome; Mice; Oxazines; Peptide Fragments; Phenylpropionates; Protein Precursors; Rats; Receptor, Insulin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors

2004

Other Studies

3 other study(ies) available for glucagon and rosiglitazone

ArticleYear
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
    Diabetes, obesity & metabolism, 2000, Volume: 2, Issue:6

    Topics: Aging; Animals; Cataract; Diabetes Mellitus, Type 2; Glucagon; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Pancreas; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Thirst; Time Factors

2000
Beneficial effect of chungkukjang on regulating blood glucose and pancreatic beta-cell functions in C75BL/KsJ-db/db mice.
    Journal of medicinal food, 2008, Volume: 11, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Fermentation; Glucagon; Glucokinase; Glycated Hemoglobin; Glycine max; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Isoflavones; Leptin; Liver; Male; Mice; Mice, Inbred C57BL; Pancreas; Rosiglitazone; Soybean Proteins; Thiazolidinediones

2008
Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: ADAM Proteins; ADAM17 Protein; Albuminuria; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucose Tolerance Test; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Kidney Diseases; Male; Membrane Proteins; Mice; Peptidyl-Dipeptidase A; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-3; Triglycerides

2013